Philip Judson Mease MD, MACR

Dr. Mease received undergraduate and medical degrees from Stanford University and completed a residency in internal medicine and a fellowship in rheumatology at the University of Washington. He directs the Rheumatology Research Division at Swedish Medical Center/Providence St. Joseph Health and is a Clinical Professor of Medicine at the University of Washington in Seattle. His major research interests include psoriatic arthritis (PsA) and spondyloarthritis (SpA). His work includes research on disease state, development of outcome measures, and determining the efficacy and safety of emerging therapies for these conditions.

Dr. Mease has authored over 490 journal articles, numerous abstracts, and book chapters. He is past president, founding organizer, and current treasurer of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and a member of its Collaborative Research Network (CRN) steering committee. He is also a member of the Assessment of Spondyloarthritis international Society (ASAS) and the Spondyloarthritis Research and Treatment Network (SPARTAN).

Dr. Mease is active in the Outcome Measures in Rheumatology Clinical Trials (OMERACT) organization as co-chair of the PsA and chronic pain working groups and as a steering committee member. He is the Scientific Director of the PsA and SpA arms of the Consortium of Rheumatology Researchers of North America (CORRONA) registry. Dr. Mease is co-chair of the PsA task force of the National Psoriasis Foundation, which in 2019 awarded him a lifetime achievement award for his work in advancing the field of PSA.